1 withdrawn. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Withdrawn 1 |
Follow Advanced Prostate Carcinoma: new trials by email Literature Review of Advanced Prostate Carcinoma trials Research Report on Advanced Prostate Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SMMART Adaptive Clinical Treatment (ACT) Trial Alectinib, Alpelisib, Anastrozole - Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm | Early Phase 1 | Withdrawn | OHSU Knight Cancer Institute | 2023-01-30 | 2024-01-23 |
Breast Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1) · Sarcoma (1)
Adnexal Diseases (1) · Breast Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Diseases, Male (1) · Genital Neoplasms, Female (1) · Genital Neoplasms, Male (1) · Gonadal Disorders (1) · Male Urogenital Diseases (1)
130-nm albumin-bound paclitaxel (1) · 2C4 antibody (1) · Ado-Trastuzumab Emtansine (1) · Albumin-Bound Paclitaxel (1) · Alpelisib (1) · Anastrozole (1) · Bevacizumab (1) · Biopsy (1) · Capecitabine (1) · Carboplatin (1) · Disulfides (1) · Fulvestrant (1) · HhAntag691 (1) · Immunoglobulin G (1) · Irinotecan (1)
OHSU Knight Cancer Institute (1)
Lara Davis (1)